Company
Arzeda
The Protein Design Company™
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Seattle, WA, United States
- Customers
- We commercialize with Fortune 500 go-to-market partners across multiple industries
- arzeda.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Arzeda develops innovative products powered by its Intelligent Protein Design Technology™, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet.
Funding snapshot
- Total raised
- $82.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.5M2025-08-28
Funding rounds
- Round, 2025
- $4.5M2025-08-28, SEC form D sold, 6 investors
- Round, 2023
- $37.9M2023-10-27, SEC form D sold, 21 investors
- Round, 2021
- $25.7M2021-07-08, SEC form D sold, 14 investors
- Round, 2020
- $3.2M2020-10-28, SEC form D sold, 3 investors
- Round, 2019
- $1M2019-11-11, SEC form D sold, 1 investor
- Round, 2017
- $10.5M2017-07-06, SEC form D sold, 5 investors
Loading relationship preview